LOVASTATIN THERAPY IN HYPERCHOLESTEROLEMIA - EFFECT ON FIBRINOGEN, HEMORRHEOLOGIC PARAMETERS, PLATELET ACTIVITY, AND RED-BLOOD-CELL MORPHOLOGY

The effect of lovastatin therapy on blood rheology was investigated in 26 hypercholesterolemic patients. Treatment with lovastatin was associated with a significant improvement in whole blood filtration time and a tendency toward normalization in red blood cell morphology. A significant increase was observed in fibrinogen level, in ADP-induced platelet aggregation, in the percentage of "big" platelets, and in platelet count. The viscosity of whole blood and plasma and the percentage of aggregated platelets did not change significantly. The cause for these hemorrheologic changes and their role influencing the coronary risk of lovastatin-treated hypercholesterolemic patients should be further investigated.